RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+15.45%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.22B
AUM Growth
+$1.22B
(+9.6%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
2.25%
Top 10 Holdings %
Top 10 Hldgs %
47.36%
Holding
68
New
14
Increased
14
Reduced
24
Closed
13
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$41.5M |
| 2 |
HCA Healthcare
HCA
|
$35.4M |
| 3 |
AbbVie
ABBV
|
$34.3M |
| 4 |
Cigna
CI
|
$32.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$28.4M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$50.3M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$41.9M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$27.2M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$25.3M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$21.2M |
Sector Composition
| 1 | Healthcare | 85.69% |
| 2 | Financials | 2.76% |
| 3 | Communication Services | 1.41% |
| 4 | Technology | 1.32% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $98.2M | 8.05% | 13,623,620 +498,026 | +4% | +$3.59M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $89.1M | 7.3% | 6,297,523 +465,295 | +8% | +$6.58M |
|
3
Bausch Health
BHC
$2.74B
| $85.4M | 7% | 384,506 +115,987 | +43% | +$25.8M |
|
|
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
| $66.7M | 5.47% | 759,479 -141,400 | -16% | -$12.4M |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $57.2M | 4.69% | 967,359 +113,386 | +13% | +$6.7M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $41.5M | 3.4% | +136,818 | New | +$41.5M |
|
|
KYTH
7
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $36.3M | 2.98% | 482,556 +257,494 | +114% | +$19.4M |
|
|
8
HCA Healthcare
HCA
$94.5B
| $35.4M | 2.9% | +390,000 | New | +$35.4M |
|
|
9
AbbVie
ABBV
$372B
| $34.3M | 2.81% | +510,010 | New | +$34.3M |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $33.7M | 2.76% | 264,075 +52,101 | +25% | +$6.64M |
|
|
CMRX
11
DELISTED
Chimerix, Inc.
CMRX
| $32.3M | 2.65% | 699,425 -145,031 | -17% | -$6.7M |
|
|
12
Cigna
CI
$80.3B
| $32.2M | 2.64% | +198,700 | New | +$32.2M |
|
13
Biogen
BIIB
$19.4B
| $32M | 2.62% | 79,118 -18,595 | -19% | -$7.51M |
|
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| $28.4M | 2.33% | +207,744 | New | +$28.4M |
|
|
RCPT
15
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $27.4M | 2.25% | 144,205 -15,208 | -10% | -$2.89M |
|
16
Jazz Pharmaceuticals
JAZZ
$7.75B
| $26.6M | 2.18% | 150,866 +50,866 | +51% | +$8.96M |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $25.6M | 2.1% | 529,199 -523,467 | -50% | -$25.3M |
|
18
Universal Health Services
UHS
$11.6B
| $25M | 2.05% | +175,965 | New | +$25M |
|
|
HNT
19
DELISTED
HEALTH NET INC
HNT
| $24.9M | 2.04% | 388,128 +117,770 | +44% | +$7.55M |
|
|
ALR
20
DELISTED
Alere Inc
ALR
| $24.3M | 1.99% | 461,170 -202,968 | -31% | -$10.7M |
|
|
NSTG
21
DELISTED
NanoString Technologies, Inc.
NSTG
| $22.5M | 1.84% | 1,459,742 +382,100 | +35% | +$5.89M |
|
|
SAGE
22
DELISTED
Sage Therapeutics
SAGE
| $21.2M | 1.74% | +290,350 | New | +$21.2M |
|
23
Insmed
INSM
$28.8B
| $21.2M | 1.74% | 867,346 -514,482 | -37% | -$12.6M |
|
24
Atara Biotherapeutics
ATRA
$84.6M
| $19.7M | 1.61% | 372,642 +107,437 | +41% | +$5.67M |
|
|
ITCI
25
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $19.5M | 1.6% | 610,171 -58,500 | -9% | -$1.87M |
|